SWOT Analysis for Edgewise Therapeutics Inc

Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Year
Stock with Low PE (PE < = 10)

Negative Breakdown First Support (LTP < S1)
Stocks with Quarter Change % less than Industry
PEG greater than Industry PEG
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Top Losers
Negative Breakdown First Support (LTP < S1)
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining profits every quarter for the past 3 quarters
RSI indicating price weakness
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter